175 related articles for article (PubMed ID: 33207264)
1. Rescue of NanoLuc luciferase-expressing Senecavirus A with oncolytic activity.
Liu F; Wang Q; Huang Y; Wang N; Shan H
Virus Res; 2021 Jan; 292():198232. PubMed ID: 33207264
[TBL] [Abstract][Full Text] [Related]
2.
Kanai Y; Kawagishi T; Matsuura Y; Kobayashi T
J Virol; 2019 Jul; 93(14):. PubMed ID: 31068423
[TBL] [Abstract][Full Text] [Related]
3. Infectious recombinant Senecavirus A expressing novel reporter proteins.
Wang M; Mou C; Chen M; Chen Z
Appl Microbiol Biotechnol; 2021 Mar; 105(6):2385-2397. PubMed ID: 33660038
[TBL] [Abstract][Full Text] [Related]
4. Construction of eGFP-Tagged Senecavirus A for Facilitating Virus Neutralization Test and Antiviral Assay.
Liu F; Huang Y; Wang Q; Shan H
Viruses; 2020 Mar; 12(3):. PubMed ID: 32150804
[TBL] [Abstract][Full Text] [Related]
5. Construction and Generation of a Recombinant Senecavirus a Stably Expressing the NanoLuc Luciferase for Quantitative Antiviral Assay.
Guo X; Zhao K; Liu X; Lei B; Zhang W; Li X; Yuan W
Front Microbiol; 2021; 12():745502. PubMed ID: 34659180
[TBL] [Abstract][Full Text] [Related]
6. Infectious Recombinant Senecavirus A Expressing p16
Gong W; Zhao X; Tang X; Gao L; Sun Y; Ma J
Int J Mol Sci; 2023 Mar; 24(7):. PubMed ID: 37047110
[TBL] [Abstract][Full Text] [Related]
7. Construction and characterization of recombinant senecavirus A expressing secreted luciferase for antiviral screening.
Wang H; Mo Y; Liu W; He Q; Ren T; Ouyang K; Chen Y; Huang W; Wei Z
J Virol Methods; 2024 Jun; 327():114932. PubMed ID: 38582378
[TBL] [Abstract][Full Text] [Related]
8. A virulent and pathogenic infectious clone of Senecavirus A.
Fernandes MHV; de Lima M; Joshi LR; Diel DG
J Gen Virol; 2021 Aug; 102(8):. PubMed ID: 34424160
[TBL] [Abstract][Full Text] [Related]
9. Construction of recombinant Newcastle disease virus Italien strain for oncolytic virotherapy of tumors.
Wei D; Sun N; Nan G; Wang Y; Liu HQ; Peeters B; Chen ZN; Bian H
Hum Gene Ther; 2012 Jul; 23(7):700-10. PubMed ID: 22372930
[TBL] [Abstract][Full Text] [Related]
10. Luciferase imaging for evaluation of oncolytic adenovirus replication in vivo.
Guse K; Dias JD; Bauerschmitz GJ; Hakkarainen T; Aavik E; Ranki T; Pisto T; Särkioja M; Desmond RA; Kanerva A; Hemminki A
Gene Ther; 2007 Jun; 14(11):902-11. PubMed ID: 17377596
[TBL] [Abstract][Full Text] [Related]
11. Characterization of a full-length infectious cDNA clone and a GFP reporter derivative of the oncolytic picornavirus SVV-001.
Poirier JT; Reddy PS; Idamakanti N; Li SS; Stump KL; Burroughs KD; Hallenbeck PL; Rudin CM
J Gen Virol; 2012 Dec; 93(Pt 12):2606-2613. PubMed ID: 22971818
[TBL] [Abstract][Full Text] [Related]
12. Engineering recombinant replication-competent bluetongue viruses expressing reporter genes for
Utrilla-Trigo S; Jiménez-Cabello L; Marín-López A; Illescas-Amo M; Andrés G; Calvo-Pinilla E; Lorenzo G; van Rijn PA; Ortego J; Nogales A
Microbiol Spectr; 2024 Mar; 12(3):e0249323. PubMed ID: 38353566
[TBL] [Abstract][Full Text] [Related]
13. Ex vivo infection of live tissue with oncolytic viruses.
Diallo JS; Roy D; Abdelbary H; De Silva N; Bell JC
J Vis Exp; 2011 Jun; (52):. PubMed ID: 21730946
[TBL] [Abstract][Full Text] [Related]
14. Genetic Modification of Oncolytic Newcastle Disease Virus for Cancer Therapy.
Cheng X; Wang W; Xu Q; Harper J; Carroll D; Galinski MS; Suzich J; Jin H
J Virol; 2016 Jun; 90(11):5343-5352. PubMed ID: 27009956
[TBL] [Abstract][Full Text] [Related]
15. Recovery of NanoLuc Luciferase-Tagged Canine Distemper Virus for Facilitating Rapid Screening of Antivirals
Liu F; Wang Q; Huang Y; Wang N; Zhang Y; Shan H
Front Vet Sci; 2020; 7():600796. PubMed ID: 33363240
[TBL] [Abstract][Full Text] [Related]
16. Rescue of Senecavirus A to uncover mutation profiles of its progenies during 80 serial passages in vitro.
Liu F; Huang Y; Wang Q; Li J; Shan H
Vet Microbiol; 2021 Feb; 253():108969. PubMed ID: 33450657
[TBL] [Abstract][Full Text] [Related]
17. A slow but steady nanoLuc: R162A mutation results in a decreased, but stable, nanoLuc activity.
Ahmed WS; Geethakumari AM; Sultana A; Fatima A; Philip AM; Uddin SMN; Biswas KH
Int J Biol Macromol; 2024 Jun; 269(Pt 1):131864. PubMed ID: 38692549
[TBL] [Abstract][Full Text] [Related]
18. Senecavirus A 2B protein suppresses type I interferon production by inducing the degradation of MAVS.
Liu H; Li K; Chen W; Yang F; Cao W; Zhang K; Li P; Tang L; Zhu Z; Zheng H
Mol Immunol; 2022 Feb; 142():11-21. PubMed ID: 34959069
[TBL] [Abstract][Full Text] [Related]
19. Insert Stability and In Vivo Testing of MicroRNA-Detargeted Oncolytic Picornaviruses.
Schulze AJ
Methods Mol Biol; 2020; 2058():77-94. PubMed ID: 31486032
[TBL] [Abstract][Full Text] [Related]
20. Genomic profile of eGFP-tagged senecavirus A subjected to serial plaque-to-plaque transfers.
Chu H; Wang L; Wang J; Zhang Y; Jin N; Liu F; Li Y
Microb Pathog; 2024 Jun; 191():106661. PubMed ID: 38657711
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
